India has taken a crucial step towards approving a vaccine for Covid-19. A committee of experts assessing coronavirus vaccines recommended that the candidate developed by University of Oxford and AstraZeneca and manufactured in India by Serum Institute of India be cleared. The Recommendations of the Subject Expert Committee of the Central Drugs Standard Control Organisation are now being assessed by the Drugs Controller General of India. It is likely to heed to the advice of the expert committee and issue a formal approval soon. As many as 300 million people will be immunised till July in the first vaccination drive. This includes health care workers, frontline workers, elderly and those with comorbidities. The expert panel did not recommend the India-made Bharat Biotech vaccine. It has asked the firm to expedite clinical trials and sought more details. Watch the full video for more.
E-Paper
